Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma

Published:2012-09-08 Issue:2 Volume:54 Page:277-283
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Forero-Torres Andres,Bartlett Nancy,Beaven Anne,Myint Han,Nasta Sunita,Northfelt Donald W.,Whiting Nancy C.,Drachman Jonathan G.,LoBuglio Albert F.,Moskowitz Craig H.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.710328

Reference31 articles.

1. Cancer Statistics, 2010

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

4. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

5. Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

2. A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors;Investigational New Drugs;2022-12-20

3. Emerging new cell therapies/immune therapies in B-cell non-Hodgkin's lymphoma;Current Problems in Cancer;2021-12

4. Immune targeted therapy for diffuse large B cell lymphoma;Blood Science;2021-10

5. CD40 Agonist Monoclonal Antibody-Mediated Hepatitis in TNF-Receptor 1 Gene Knockout Mice;Biomedicines;2021-07-22